Paul Lelieveld
Founding Partner @ Meneldor
Eindhoven, The Netherlands
Paul Lelieveld is a Founding Partner at Meneldor.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Paul Lelieveld invests in
Stages Paul Lelieveld invests in
Countries Paul Lelieveld invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (33%)
- Biopharma 1 (17%)
- Consulting 1 (17%)
- Health Care 1 (17%)
- Therapeutics 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Debt Financing 1 (17%)
- Convertible Note 1 (17%)
Country
- Norway 1 (17%)
- Germany 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | $3M / Series A / Nov 24, 2022 | ||
| Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | $1.3M / Seed / May 03, 2022 | ||
| Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. | Convertible Note / Apr 01, 2022 | ||
| Atriva Therapeutics is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections. Atriva Therapeutics completed preclinical development of ATR-002 and recently filed a request for scientific advice from a European regulatory authority to provide guidance on the executed preclinicaldevelopment program and the planned ATR-002 Phase I study in healthy volunteers. | $10.1M / Debt Financing / Aug 12, 2020 | ||
| Atriva Therapeutics is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections. Atriva Therapeutics completed preclinical development of ATR-002 and recently filed a request for scientific advice from a European regulatory authority to provide guidance on the executed preclinicaldevelopment program and the planned ATR-002 Phase I study in healthy volunteers. | Series A / Jan 03, 2019 | ||
| See all 6 investments → | |||
Co-Investors
About Meneldor
Meneldor is a biopharmaceutical investment company .
Meneldor Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Paul Lelieveld
Founding Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Paul Lelieveld invest in?
Paul Lelieveld invests primarily in Biotechnology, Biopharma and Consulting startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Paul Lelieveld?
Public channels for Paul Lelieveld include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Paul Lelieveld last invest?
The most recent investment recorded for Paul Lelieveld closed in Nov 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
